Takeda Tomoki, Komiya Yukiko, Koga Takayuki, Ishida Takumi, Ishii Yuji, Kikuta Yasushi, Nakaya Michio, Kurose Hitoshi, Yokomizo Takehiko, Shimizu Takao, Uchi Hiroshi, Furue Masutaka, Yamada Hideyuki
From the Laboratory of Molecular Life Sciences and
From the Laboratory of Molecular Life Sciences and.
J Biol Chem. 2017 Jun 23;292(25):10586-10599. doi: 10.1074/jbc.M116.764332. Epub 2017 May 9.
Dioxin and related chemicals alter the expression of a number of genes by activating the aryl hydrocarbon receptors (AHR) to produce a variety of disorders including hepatotoxicity. However, it remains largely unknown how these changes in gene expression are linked to toxicity. To address this issue, we initially examined the effect of 2,3,7,8-tetrachrolodibenzo--dioxin (TCDD), a most toxic dioxin, on the hepatic and serum metabolome in male pubertal rats and found that TCDD causes many changes in the level of fatty acids, bile acids, amino acids, and their metabolites. Among these findings was the discovery that TCDD increases the content of leukotriene B4 (LTB4), an inducer of inflammation due to the activation of leukocytes, in the liver of rats and mice. Further analyses suggested that an increase in LTB4 comes from a dual mechanism consisting of an induction of arachidonate lipoxygenase-5, a rate-limiting enzyme in LTB4 synthesis, and the down-regulation of LTC4 synthase, an enzyme that converts LTA4 to LTC4. The above changes required AHR activation, because the same was not observed in AHR knock-out rats. In agreement with LTB4 accumulation, TCDD caused the marked infiltration of neutrophils into the liver. However, deleting LTB4 receptors (BLT1) blocked this effect. A TCDD-produced increase in the mRNA expression of inflammatory markers, including tumor-necrosis factor and hepatic damage, was also suppressed in BLT1-null mice. The above observations focusing on metabolomic changes provide novel evidence that TCDD accumulates LTB4 in the liver by an AHR-dependent induction of LTB4 biosynthesis to cause hepatotoxicity through neutrophil activation.
二噁英及相关化学物质通过激活芳烃受体(AHR)改变多种基因的表达,从而引发包括肝毒性在内的多种紊乱。然而,基因表达的这些变化如何与毒性相关联在很大程度上仍不清楚。为了解决这个问题,我们首先研究了毒性最强的二噁英之一2,3,7,8-四氯二苯并-对-二噁英(TCDD)对雄性青春期大鼠肝脏和血清代谢组的影响,发现TCDD会导致脂肪酸、胆汁酸、氨基酸及其代谢物水平发生许多变化。在这些发现中,有一项是发现TCDD会增加大鼠和小鼠肝脏中白三烯B4(LTB4)的含量,LTB4是一种因白细胞激活而产生的炎症诱导剂。进一步分析表明,LTB4的增加源于一种双重机制,该机制包括诱导花生四烯酸脂氧合酶-5(LTB4合成中的限速酶)以及下调将LTA4转化为LTC4的LTC4合酶。上述变化需要AHR激活,因为在AHR基因敲除大鼠中未观察到同样的情况。与LTB4积累一致,TCDD导致中性粒细胞大量浸润肝脏。然而,删除LTB4受体(BLT1)可阻断这种效应。在BLT1基因缺失的小鼠中,TCDD引起的包括肿瘤坏死因子和肝损伤在内的炎症标志物mRNA表达增加也受到抑制。上述关于代谢组变化的观察提供了新的证据,即TCDD通过AHR依赖的LTB4生物合成诱导在肝脏中积累LTB4,从而通过中性粒细胞激活导致肝毒性。